Comment on

• Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.

  Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR. Dahl R, et al. J Allergy Clin Immunol. 2006 Aug;118(2):434-40. doi: 10.1016/j.jaci.2006.05.003. J Allergy Clin Immunol. 2006. PMID: 16890769 Clinical Trial.
• Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

  Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A, André C, de Beaumont O, Melac M. Didier A, et al. J Allergy Clin Immunol. 2007 Dec;120(6):1338-45. doi: 10.1016/j.jaci.2007.07.046. Epub 2007 Nov 1. J Allergy Clin Immunol. 2007. PMID: 17935764 Clinical Trial.
• Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.

  Wahn U, Tabar A, Kuna P, Halken S, Montagut A, de Beaumont O, Le Gall M; SLIT Study Group. Wahn U, et al. J Allergy Clin Immunol. 2009 Jan;123(1):160-166.e3. doi: 10.1016/j.jaci.2008.10.009. Epub 2008 Nov 29. J Allergy Clin Immunol. 2009. PMID: 19046761 Clinical Trial.
• Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents.

  Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner DP. Blaiss M, et al. J Allergy Clin Immunol. 2011 Jan;127(1):64-71, 71.e1-4. doi: 10.1016/j.jaci.2010.11.034. J Allergy Clin Immunol. 2011. PMID: 21211642 Clinical Trial.
• Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults.

  Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI. Nelson HS, et al. J Allergy Clin Immunol. 2011 Jan;127(1):72-80, 80.e1-2. doi: 10.1016/j.jaci.2010.11.035. J Allergy Clin Immunol. 2011. PMID: 21211643 Clinical Trial.